Ann Li Lee
Direktor/Vorstandsmitglied bei JW (CAYMAN) THERAPEUTICS CO. LTD
Aktive Positionen von Ann Li Lee
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JW (CAYMAN) THERAPEUTICS CO. LTD | Direktor/Vorstandsmitglied | 22.05.2020 | - |
Independent Dir/Board Member | 29.08.2023 | - | |
CELGENE | Corporate Officer/Principal | 01.03.2018 | - |
Karriereverlauf von Ann Li Lee
Ehemalige bekannte Positionen von Ann Li Lee
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.05.2009 | - |
JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01.11.2017 | - |
Ausbildung von Ann Li Lee
Yale University | Doctorate Degree |
Cornell University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
China | 2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
Private Unternehmen | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Ann Li Lee
- Erfahrung